RECIBOKIBART
UNII D859Q6K2XE

Substance Identification & Data

This profile provides standardized clinical and technical data for Recibokibart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) D859Q6K2XE.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2744274-17-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

D859Q6K2XE

CAS Registry Number

2744274-17-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

RECIBOKIBART

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C211763

National Cancer Institute reference terminology for clinical and research data.

INN ID

13255

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Recibokibart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

RECIBOKIBART

Common Names & Synonyms

H-GAMMA1 HEAVY CHAIN HUMANIZED (1-448) (VH (HOMO SAPIENS IGHV1-2*06 (88.8%) -(IGHD) -IGHJ6*01 (90.9%) T123>L (114), CDR-IMGT (8.8.12) (26-33.51-58.97-108)) (1-119) -HOMO SAPIENS IGHG1*03, G1M3, NG1M1 CH1 R120, CH3 E12, M14, G1V14 CH2 A1.3, A1.2 (CH1 R120 (216) (120-217), HINGE 1-15 (218-232), CH2 L1.3>A (236), L1.2>A (237) (233-342), CH3 E12 (358), M14 (360) (343-447), CHS K2>DEL (448)) (120-448)), (222-215')-DISULFIDE WITH L-KAPPA LIGHT CHAIN HUMANIZED (1'-215') (V-KAPPA (HOMO SAPIENS IGKV3-20*01 (90.6%) -IGKJ2*01 (100%), CDR-IMGT (7.3.9) (27'-33'.51'-53'.90'-98')) (1'-108') -HOMO SAPIENS IGKC*01 (100%) KM3 A45.1, V101 (C-KAPPA A45.1 (154'), V101 (192')) (109'-215')); DIMER (228-228'':231-231'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, GLYCOFORM ALFA

IMMUNOGLOBULIN G1 (236-ALANINE,237-ALANINE,DE-C-TERMINAL-LYSINE), ANTI-(HUMAN INTERLEUKIN 36 RECEPTOR) (HUMAN-MUS MUSCULUS MONOCLONAL HB0034 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL HB0034 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS IL1RL2 (INTERLEUKIN 1 RECEPTOR LIKE 2, IL1 RECEPTOR-RELATED PROTEIN 2, IL1RRP2, IL1RRP2, IL-36 RECEPTOR, IL-36R)), HUMANIZED MONOCLONAL ANTIBODY

RECIBOKIBART [INN]

External Clinical & Regulatory Resources

Previous UNIID856J1047R

Next UNIID85A5NX9FD